Creating Asthma Measurements through the MORRE Study
Trial Objectives
.jpg?lang=en-US)
Researchers want to develop new ways to measure if a patient’s asthma is improving or worsening. During the study, participants will use a FitBit® to measure steps per day and sleep quality. Participants also will answer a custom survey using their own smartphone. Researchers hope to determine the best ways to show how well asthma is controlled while being treated with omalizumab, a common asthma medication.
Who Can Participate
Participants between 18 and 85 years of age with moderate-to-severe asthma at the time of enrollment, and who are eligible for omalizumab therapy.
Age: 18-85 Gender: Any
Estimated Time Commitment
Participants will have a 2-3 in-person clinic visits of 45-90 minutes over 6-12 months.
Time Commitment Details
Participants will also complete monthly surveys and questionnaires at home during the 12-month period.
Payment & Reimbursement
Payment: Provided
Travel Reimbursement: Not Available
Trial Contact
For more information, contact:
Stephanie Leonard
303.270.2411
Trial Location
National Jewish Main Campus, Denver, CO
Trial Sponsors
National Jewish Health
Principal Investigators
Eileen Wang, MD, MPH
Co-Investigators
-
Flavia Cecilia Lega Hoyte, MD
-
Laurie A. Manka, MD
-
Kanao Otsu, MD, MPH